Evidence map›Paper›PMID 27069748›Full record

ArticleSurgical neurology international2016

Paraganglioma of the filum terminale mimicking neurinoma: Case report.

Said Hilmani, Trezor Ngamasata, Mehdi Karkouri, Abdessamad Elazahri

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Paraganglioma of the filum terminal: Case report and review of the literature.International journal of surgery case reports · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Said HilmaniDepartment of Neurosurgery, Ibn Rochd UHC, Hassan II University, Casablanca, Morocco.
Trezor NgamasataDepartment of Neurosurgery, Ibn Rochd UHC, Hassan II University, Casablanca, Morocco.
Mehdi KarkouriDepartment of Anatomic Pathology, Ibn Rochd UHC, Hassan II University, Casablanca, Morocco.
Abdessamad ElazahriDepartment of Neurosurgery, Ibn Rochd UHC, Hassan II University, Casablanca, Morocco.
Centre Hospitalier Universitaire Ibn Rochd · MAUniversity of Hassan II Casablanca · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParaganglioma of the filum terminale is an uncommon tumor of cauda equina region. Lumbar radiculopathies are revelations that can get complicated from cauda equina syndrome. Magnetic resonance imaging (MRI) allows the diagnosis without distinguishing it from a neurofibroma. Only histopathological study can bring certainty in the diagnosis. The treatment of choice is a complete removal. CASE DESCRIPTION: We report a case of paraganglioma of the filum terminale in a 74-year-old female patient, admitted for cauda equina syndrome, which has been progressing for 2 years. MRI of medulla objectified an extramedullary lesion at L3-L4, diagnosed as neurinoma. A complete resection of the tumor was performed with a section of the filum terminale, which she was taking since birth. Histology confirmed the diagnosis of paraganglioma. The clinical course was characterized by a complete recovery of the deficit.

conclusionThrough this case report, the authors discuss clinical and radiological aspects of this tumor, as well as the management in the light of published data.

Indexed as

Cauda equinaneuroendocrine tumorparaganglioma

Identifiers

PMID27069748
PMCPMC4802983
OpenAlexW2316708256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.